An official with the Centers for Disease Control and Prevention (CDC) used data from a flawed preprint study that exaggerated the risk of death for children from COVID-19 in her presentations to CDC and U.S. Food and Drug Administration advisors who were responsible for recommending Pfizer and Moderna’s vaccines for infants and young children.
An official with the Centers for Disease Control and Prevention (CDC) used data from a flawed preprint study that exaggerated the risk of death for children from COVID-19 in her presentations to CDC and U.S. Food and Drug Administration (FDA) advisors who were responsible for recommending Pfizer and Moderna’s vaccines for infants and young children.
The study, first published May 25 on the medRxiv preprint server, was authored by a group of U.K. researchers. On June 28, the authors published a revised version of the study, after critics questioned some of their original findings. “It’s really disturbing that data this poor made its way into the meetings to discuss childhood COVID and that it took me less than a few minutes to find a major flaw (and then I found many more as I looked deeper),” said Kelley K, who was the first to point out some of the study’s flaws on her website COVID-Georgia.com.